Identifying Patient Responders & Non-responders Through CXCR4 Targeted Theranostic Approaches for Central Nervous System Lymphoma (CNSL)
Time: 12:15 pm
day: C&S Track AM
Details:
- Uncovering the dose-finding clinical phase I/II study
- Predicting treatment responses
- Sharing clinical design
